fusarium has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasopoulou, A; DiPippo, AJ; Kontoyiannis, DP | 1 |
| Au-Yeung, R; Chan, TS; Chim, CS; Kwong, YL; Wong, SC | 1 |
| Beyan, C; Gönlüm, A; Gün, H; Kömürcü, S; Saraçli, MA; Yalçin, A; Yildiran, ST | 1 |
1 review(s) available for fusarium and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
Topics: Adenine; Aged; Anticarcinogenic Agents; Antifungal Agents; Aspergillosis; Aspergillus; Female; Fungi; Fusariosis; Fusarium; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mucorales; Mycoses; Piperidines | 2020 |
2 other study(ies) available for fusarium and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fever; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphadenopathy; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Opportunistic Infections; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Remission Induction; Treatment Outcome | 2017 |
Fusarium fungaemia in severely neutropenic patients.
Topics: Aged; Female; Fungemia; Fusarium; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia | 1998 |